DELNOVA was selected to present at IMCAS, the premier global congress in aesthetic medicine for the final stage of the Innovation Tank Competition. Following a rigorous selection process, IMCAS spotlights groundbreaking startups, with transformative products and research, capable of reshaping dermatology, plastic surgery, and aging science. DelNova is honored to participate in this highly competitive forum.
Posts Tagged: start-ups
Fast Growing PropTech Startup Flexo Launches its Coworking Marketplace in 2 More Cities
Flexo, a leading proptech start-up in India, has announced the launch of its coworking marketplace in Pune and Hyderabad. The platform will offer individuals and businesses a flexible and cost-effective way to work in a professional environment. The Flexo marketplace connects businesses and individuals with a variety of coworking spaces in Pune and Hyderabad, offering a range… Read more »
Flexo Launches Coworking Marketplace in India to Tap into Burgeoning Demand of Flexible Workspaces
Flexo’s coworking marketplace makes it fast and easy for global companies and startups to find and book the best suited workspaces for their requirements in India. Ranging from coworking spaces, managed offices, built-to-suit options, ready to occupy spaces that come with flexibility alongside zero capital expenditure, Flexo has it all. As a one stop stop… Read more »
Sandbox Philippines Fil-Am meetup in San Francisco!
Sandbox Philippines, powered by Kada and in collaboration with Thruline Networks, Leaders Innovate, Dynamico Space, and powerful leaders in the Filipino-American ecosystem community, hosted the event The Time is Now: Leading through Challenging Times on July 27, 2022 at Dynamico Space in the Filipino Building in San Francisco, CA. This event was recorded and will… Read more »
DelNova to Advance ReViVox™, A Groundbreaking Rescue Drug to Reverse Botulinum Toxin Neuromodulator Complications
DelNova, a biopharmaceutical company targeting unmet medical needs, by developing clinically validated molecules linked to advances in drug delivery, announced today that the company is making substantive progress in developing the first ever product to reverse complications arising from administration of botulinum toxin neuromodulators, such as BOTOX®, Dysport®, XEOMIN®, and Jeuveau®. According to the syndicated… Read more »
